Hepatocellular Carcinoma P53 G > T Transversions at Codon 249: the Fingerprint of Aflatoxin Exposure?
Overview
Affiliations
The molecular epidemiology of p53 mutations allows the possibility of correlating particular mutations with specific environmental carcinogens and establishing one step in the causal pathway between exposure to carcinogens and the development of cancer. A striking example is the G > T transversion at the third base pair of codon 249 observed in liver cancer patients possibly exposed to high levels of aflatoxins in their agricultural products. In this paper, we describe a systematic review of the literature and access the quality of the available data. We found methodologic limitations in the studies. In particular, the key independent variable, aflatoxin exposure, was not assessed in these studies, with the exception of one study that measured a marker of exposure. Instead, nationality, geographic residence, or geographic site of hospital were used as surrogate markers for exposure. Patients from areas with high aflatoxin levels were more likely to have p53 mutations than were patients from areas with low aflatoxin levels. In the group with p53 mutations, patients from areas with high aflatoxin levels had higher proportions of mutations with codon 249 G > T transversions. The differences in proportions with p53 mutations were significant, as were the differences in proportions of codon 249 G > T transversions among patients with p53 mutations. Aflatoxin may increase the proportion of p53 mutations by causing a single mutation, the codon 249 G > T transversion, thus explaining some of the excess liver cancer associated with aflatoxin exposure. However, it is premature to conclude that p53 mutations are established markers for environmental carcinogens.
Aflatoxins: History, Significant Milestones, Recent Data on Their Toxicity and Ways to Mitigation.
Pickova D, Ostry V, Toman J, Malir F Toxins (Basel). 2021; 13(6).
PMID: 34205163 PMC: 8227755. DOI: 10.3390/toxins13060399.
Cytotoxic Effect of Bromelain on HepG2 Hepatocellular Carcinoma Cell Line.
Murthy S, Narsaiah T Appl Biochem Biotechnol. 2021; 193(6):1873-1897.
PMID: 33735410 DOI: 10.1007/s12010-021-03505-z.
Alvarez-Escribano I, Sasse C, Bok J, Na H, Amirebrahimi M, Lipzen A BMC Biol. 2019; 17(1):88.
PMID: 31711484 PMC: 6844060. DOI: 10.1186/s12915-019-0702-0.
Benkerroum N Int J Environ Res Public Health. 2019; 16(19).
PMID: 31569703 PMC: 6801849. DOI: 10.3390/ijerph16193633.
Hepatocellular carcinoma: focus on different aspects of management.
Waly Raphael S, Yangde Z, Yuxiang C ISRN Oncol. 2012; 2012:421673.
PMID: 22655206 PMC: 3359687. DOI: 10.5402/2012/421673.